Page last updated: 2024-11-08

bis(2,3,3,3-tetrachloropropyl) ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(2,3,3,3-tetrachloropropyl) ether: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID518659
SCHEMBL ID588740
MeSH IDM0069138

Synonyms (36)

Synonym
einecs 204-870-4
monsanto cp-16226
ai3-25456
s 421
octachlorodipropylether
bis(2,3,3,3-tetrachloropropyl) ether
brn 1778336
ent 25,456
propane, 1,1'-oxybis(2,3,3,3-tetrachloro-
s-421
1,1'-oxybis(2,3,3,3-tetrachloropropane)
propane, 1,1'-oxybis[2,3,3,3-tetrachloro-
ether, bis(2,3,3,3-tetrachloropropyl)
1,1,1,2-tetrachloro-3-(2,3,3,3-tetrachloropropoxy)propane
127-90-2
A805765
1,1,1,2-tetrakis(chloranyl)-3-[2,3,3,3-tetrakis(chloranyl)propoxy]propane
S421 ,
4-01-00-01445 (beilstein handbook reference)
ccris 8473
FT-0603335
AKOS015899545
SCHEMBL588740
bis(2,3,3,3-tetrachloropropyl)ether
monsanto 16226
octachlorodipropyl ether
LNJXZKBHJZAIKQ-UHFFFAOYSA-N
octachloro-di-n-propyl ether
2,3,3,3,2',3',3',3'-octachlorodipropyl ether
J-005553
s 421, pestanal(r), analytical standard
s 421 10 microg/ml in cyclohexane
DTXSID40861778
Q18411968
s 421 100 microg/ml in acetonitrile
1,1'-oxybis[2,3,3,3-tetrachloro]propane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (33.33)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]